Takkenberg R Bart
机构: Gastroenterologist at Amsterdam University Medical Centers, location AMC
每年引用次数
引用次数
引用: 2,405
H-指数: 27
I10-指数 : 57
出版物: 185
Markers of response in chronic hepatitis B patients treated with a combination of peginterferon-alfa 2a and adefovir dipivoxil
R.B. Takkenberg
9789090263045
1
2011
278 AUGMENTED HEPATITIS B SPECIFIC T CELL RESPONSE AFTER CLEARANCE OF CHRONIC HEPATITIS B
A. de Niet , M.J. Tempelmans Plat-Sinnige , R.B. Takkenberg , H.W. Reesink
Journal of Hepatology 54
1
2011
Upregulation of CXCR3 expression on CD8+ T cells due to the pervasive influence of chronic hepatitis B and C virus infection.
A. de Niet , J. de Bruijne , M.J. Tempelmans Plat-Sinnige , R.B. Takkenberg
Human Immunology 74 ( 8) 899 -906
4
2013
Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.
U. Lopatin , H.W. Reesink , A. de Niet , R.B. Takkenberg
Scandinavian Journal of Gastroenterology 47 ( 4) 475 -481
28
2012
415 SNP rs12356193 AND PLASMA CARNITINE LEVELS ARE ASSOCIATED WITH HBsAg LOSS AFTER COMBINATION TREATMENT WITH PEGINTERFERON AND ADEFOVIR
L. Jansen , A. de Niet , E.P. van Iperen , K.A. van Dort
Journal of Hepatology 58
2013
P181 GENE SET ENRICHMENT ANALYSIS IN BASELINE LIVER BIOPSIES OF CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON-ALFA AND ADEFOVIR
L. Jansen , A. de Niet , Z. Makowska , M.T. Dill
Journal of Hepatology 60 ( 1)
2014
753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR
L. Jansen , R.B. Takkenberg , A. de Niet , H.L. Zaaijer
Journal of Hepatology 58 S305
3
2013
O.1.1 Development of a new real-time PCR for the detection of covalently closed circular DNA (cccDNA) in plasma of chronic hepatitis B patients
R.B. Takkenberg , H.L. Zaaijer , S. Menting , V. Terpstra
Journal of Clinical Virology 44
2009
O.1.2 Hepatitis B susceptibility to lamivudine restored by resistance to adefovir
H.L. Zaaijer , R.B. Takkenberg , C.J. Weegink , S.P.H. Rebers
Journal of Clinical Virology 44
2009
P685 BASELINE LIVER BIOPSY CHARACTERISTICS ASSOCIATED WITH RESPONSE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON-ALFA AND ADEFOVIR
L. Jansen , R.B. Takkenberg , A. de Niet , V. Terpstra
Journal of Hepatology 60 ( 1)
2014
LP29 : A randomised prospective open-label trial comparing peginterferon + adefovir and peginterferon + tenofovir versus no treatment in hbeag negative chronic hepatitis b patients with low viral load: analysis of week 48 results
A. de Niet , L. Jansen , F. Stelma , S.B. Willemse
Journal of Hepatology 62
2015
P0490 : NK cell dynamics in chronic hepatitis B patients are associated with HBsAg clearance after combination treatment with peginterferon ALFA-2A and adefovir
F. Stelma , A. de Niet , L. Jansen , R.B. Takkenberg
Journal of Hepatology 62
2015
Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
H.L. Zaaijer , R.B. Takkenberg , C.J. Weegink , S.P.H. Rebers
Journal of Medical Virology 81 ( 3) 413 -416
6
2009
Validation of a Sensitive and Specific Real-Time PCR for Detection and Quantitation of Hepatitis B Virus Covalently Closed Circular DNA in Plasma of Chronic Hepatitis B Patients
R.B. Takkenberg , H.L. Zaaijer , R. Molenkamp , S. Menting
Journal of Medical Virology 81 ( 6) 988 -995
24
2009
Lost in translation: confusion on resection and dissection planes hampers the interpretation of pathology reports for perihilar cholangiocarcinoma
L. Franken , E. Roos , E. Soer , J. Van Hooft
Hpb 22
2020
Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract
E. Roos , E.C. Soer , S. Klompmaker , L.L. Meijer
Critical Reviews in Oncology Hematology 140 8 -16
10
2019
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
R.B. Takkenberg , B.C. Vrouenraets , A.N. van Geel , O.E. Nieweg
Journal of Surgical Oncology 91 ( 2) 107 -111
26
2005
Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir.
N.A. Kootstra , H.W. Reesink , S.B. Willemse , L. Jansen
Antiviral Research 131 148 -155
7
2016
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview.
Diederick J. van Doorn , Robert Bart Takkenberg , Heinz-Josef Klümpen
Pharmaceuticals, policy and law 14 ( 1) 3
11
2020
New onset non-alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors.
Tara Michella Mackay , Cansu Güney Genç , Robert Bart Takkenberg , Marc Gerard Besselink
Journal of Surgical Oncology 117 ( 7) 1548 -1555
1
2018